The Minnesota Department of Health has reported two variant H3N2 (H3N2v) flu infections, both involving young people who ...
The phase IIIA trials randomized 792 patients ages 12 and older with severe asthma in a 2:1 ratio to depemokimab (100 mg ...
Dr. Steve Caffé is an accomplished industry executive with over 25 years of expertise in global product development and ...
The combination of belrestotug and dostarlimab significantly improved response rates in patients with previously untreated ...
Patients with advanced SSC of the anal canal have a marked survival benefit when immunotherapy is added to standard-of-care ...